Tag: COVID-19

Published by: The Canadian Press
Published on: June 13, 2025
By Nicole Ireland

TORONTO – As Dr. Theresa Tam prepares to leave her position next week, Canada’s top doctor says it’s more important than ever for Canada to stand up for science and combat disinformation.

She’s held the role of chief public health officer for eight years, but became a household name in the last five years as she led the country’s public health response to the COVID-19 pandemic.

Her term ends June 20 and she doesn’t have another job lined up, Tam said in a wide-ranging interview Friday that touched on her desire to be remembered for more than COVID, her passion for health equity and the musical side of her the public hasn’t seen.

Comments closed

vaccines

Kennedy dismisses entire US CDC vaccine panel, replacing all 17 members

Published June 9, 2025

Published by: Reuters
Published on: June 9, 2025
By Ahmed Aboulenein, Michael Erman, Julie Steenhuysen

WASHINGTON, June 9 (Reuters) – Health Secretary Robert F. Kennedy Jr. has fired all members sitting on a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is reconstituting the committee, his department said on Monday.

Kennedy removed all 17 members of the Advisory Committee on Immunization Practices, the Department of Health and Human Services said in a statement, and is in the process of considering new members to replace them.

Comments closed

vaccines

Exclusive: CDC expert resigns from COVID vaccines advisory role, sources say

Published June 3, 2025

Published by: Reuters
Published on: June 3, 2025
By Julie Steenhuysen, Michael Erman, Dan Levine

Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos of the U.S. CDC resigned on Tuesday as co-leader of a working group that advises outside experts on COVID-19 vaccines and is leaving the agency, two sources familiar with the move told Reuters.

Panagiotakopoulos said in an email to work group colleagues that her decision to step down was based on the belief she is “no longer able to help the most vulnerable members” of the U.S. population.

In her role at the Centers for Disease Control and Prevention’s working group of the Advisory Committee on Immunization Practices, she co-led the gathering of information on topics for presentation.

Her resignation comes one week after Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic who oversees the CDC, the Food and Drug Administration and the National Institutes of Health, said the COVID vaccine for healthy children and healthy pregnant women had been removed from the CDC’s recommended immunization schedule.

Comments closed

vaccines

RFK Jr.’s stance on Covid vaccines for pregnant women is profoundly unethical

Published June 3, 2025

Published by: STAT
Published on: June 3, 2025
By Ruth R. Faden

Health and Human Services Secretary Robert Kennedy’s proposal to end the government’s existing Covid vaccine recommendation for healthy pregnant women, if enacted, will be a major setback to decades’ worth of efforts to advance the health of pregnant people and their babies.

It also profoundly unethical.

Pregnant people are consistently left behind in biomedical R&D in ways that are deeply harmful to the health of both mother and child. In the decade before the Covid pandemic, consensus reports emerged denouncing this pregnancy evidence gap and providing road maps for how to ethically generate evidence during pregnancy within the confines of existing research regulations. I co-led one of these efforts, the PREVENT project, initiated in response to the Zika epidemic and completed in fall 2019. PREVENT specifically focused on how to ethically include pregnant women in the development and deployment of new vaccines for emerging pandemic threats.

Comments closed

pandemic response

COVID-19 Disease Burden Remains Greater Than Influenza, Study Shows

Published May 31, 2025

Published by: Forbes
Published on: May 31, 2025
By Dave Wessner

Researchers in Denmark conducted a large-scale evaluation of the disease burdens associated with COVID-19 and influenza. Their conclusion? COVID-19 has a greater impact than influenza, resulting in more hospitalizations and deaths. These findings, they note, emphasize the continued need for a strong public health response.

COVID-19 Exhibits Greater Disease Burden Than Influenza

To compare the disease burden of COVID-19 and influenza, the researchers evaluated data available from Danish health registries from May 16, 2022 to June 7, 2024. The results were published in The Lancet Infectious Diseases. A commentary about the findings was published in the same issue of the journal.

During this period, the risk of hospitalization due to COVID-19 was approximately two times higher than the risk of hospitalization due to influenza. The risk of death was approximately three times higher. The researchers note that these increased risks were greater during the first year of the study period but still were evident during the second year. The risk of mortality, for example, was five times greater for COVID-19 during the first year of the study. That increased risk dropped during the second year, but COVID-19 still had a two and a half times greater risk of mortality than influenza.

Comments closed

vaccines

FDA approves a next-generation Covid vaccine from Moderna, with restrictions

Published May 31, 2025

Published by: STAT
Published on: May 31, 2025
By Helen Branswell

The Food and Drug Administration approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s existing Covid shot, Spikevax, does not currently face.

The new vaccine, which will be marketed under the name mNexspike, will not immediately replace Spikevax. A statement from the company said both vaccines will be available on the market for the time being.

“The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from Covid-19,” Moderna CEO Stéphane Bancel said in the statement. “Covid-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone.”

Comments closed

New COVID strain found in Montreal wastewater: health ministry

Electron microscope image of SARS-CoV-2 virus particles. Virus particles are shown emerging from the surface of cells cultured in the lab. Image captured and colourized at NIAID’s Rocky Mountain Laboratories in Hamilton, Montana. Photo by: NIAID. Creative Commons CC BY 2.0 DEED Attribution 2.0 Generic license: https://creativecommons.org/licenses/by/2.0/.

Quebec

New COVID strain found in Montreal wastewater: health ministry

Published May 29, 2025

Published by: Montreal Gazette
Published on: May 29, 2025
By Leora Schertzer

SARS-CoV-2, the virus that causes COVID-19, has mutated into two new variants that are circulating across Asia, Europe and North America, and Quebec’s public health authority warns one of the strains was detected in Montreal wastewater data.

The variant found in Quebec, XFG, has also been detected in wastewater in other parts of Canada, the United States, and Europe. Another new strain, NB.1.8.1, is associated with a rise in COVID cases and hospitalizations in China, Hong Kong, India, Taiwan, Thailand, and Singapore, according to Marie-Pierre Blier, a spokesperson from the health ministry.

Although XFG has made its way to Quebec, public health authorities assure there is no need to panic. Blier wrote in an email that it hasn’t markedly impacted public health, adding that the ministry continues to monitor the situation closely.

Comments closed

vaccines

COVID vaccine ‘strongly recommended’ during pregnancy, Canadian doctors say

Published May 28, 2025

Published by: CTV News / The Canadian Press
Published on: May 28, 2025

TORONTO — Canada’s gynecologists say COVID-19 vaccination “remains safe and strongly recommended” during pregnancy and while breastfeeding.

The Society of Obstetricians and Gynaecologists of Canada issued the assurance Wednesday, a day after U.S. Health Secretary Robert F. Kennedy Jr. — a longtime anti-vaccine activist — declared the shot is no longer recommended for healthy children and pregnant women south of the border.

Pregnant women who become infected with COVID-19 are at higher risk of severe illness requiring hospitalization and intensive care than women who are not pregnant, the SOGC said.

Getting the COVID-19 vaccine also helps protect against serious complications associated with the virus, such as preterm birth, it said.

Comments closed

kakistocracy

Doctors fear ‘devastating consequences’ for pregnant people after RFK Jr order on Covid-19 boosters

Published May 28, 2025

Published by: The Guardian
Published on: May 28, 2025
By Jessica Glenza

Kennedy’s unilateral decision to change the CDC’s recommended immunization schedule for Covid-19 vaccines demonstrates once again why he is completely unqualified to be the HHS secretary.

In Congressional testimony on May 14, Kennedy said, ‘I don’t think people should be taking medical advice from me.’ Yet two weeks later he is making arbitrary public health decisions, defying norms, and with no accountability.

— Dr Robert Steinbrook, research director at consumer rights group Public Citizen

Comments closed

kakistocracy

RFK Jr says no COVID vaccines for healthy children, pregnant women

Published May 27, 2025

Published by: CIDRAP
Published on: May 27, 2025
By Stephanie Soucheray

Today Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. made another sweeping change to the US vaccine landscape, saying the Centers for Disease Control and Prevention (CDC) has removed its recommendation of the COVID-19 vaccine for healthy children and pregnant women.

“I couldn’t be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant woman has been removed from the CDC recommended immunization schedule,” Kennedy said in a video message, flanked by Martin Makary, MD, MPH, commissioner of the Food and Drug Administration, and Jay Bhattacharya, MD, PhD, director of the National Institutes of Health.

The move comes just 1 week after the FDA announced—via an opinion piece in the New England Journal of Medicine—that the vaccine would now be offered only to adults 65 years and older or those with underlying conditions that made them vulnerable to severe COVID-19.

Today’s video message is short and direct but is already causing confusion, as pregnancy itself is considered a risk factor for severe COVID-19.

Comments closed

new wave

U.S. reports cases of new COVID variant NB.1.8.1 behind surge in China

Published May 23, 2025

Published by: CBS News
Published on: May 23, 2025
By Alexander Tin

The Centers for Disease Control and Prevention’s airport screening program has detected multiple cases of the new COVID-19 variant NB.1.8.1, which has been linked to a large surge of the virus in China.

Cases linked to the NB.1.8.1 variant have been reported in arriving international travelers at airports in California, Washington state, Virginia and the New York City area, according to records uploaded by the CDC’s airport testing partner Ginkgo Bioworks.

Details about the sequencing results, which were published in recent weeks on the GISAID, or Global Initiative on Sharing All Influenza Data, virus database, show the cases stem from travelers from a number of countries, including Japan, South Korea, France, Thailand, the Netherlands, Spain, Vietnam, China and Taiwan. The travelers were tested from April 22 through May 12, the records show.

Comments closed

kakistocracy

The FDA’s misguided new Covid vaccine policy repeats past mistakes

Published May 21, 2025

Published by: MSNBC
Published on: May 21, 2025
By Dr. Kavita Patel

The Food and Drug Administration is rewriting America’s Covid vaccine playbook — and not for the better. Its new guidance would trade the clarity and reach of our current vaccination strategy for a confusing age-based and risk-based framework that simply doesn’t fit the realities of Americans’ health. As a primary care physician who has spent years on the front lines of pandemic response, I see this as a step backward that ignores both the lessons of our past and the needs of our most vulnerable patients.

The FDA’s proposed framework eerily mirrors the segmentation we attempted in fall 2021 with Covid boosters. When boosters initially rolled out in September 2021, the FDA authorized them only for specific groups: adults 65 and older, those 18-64 with high-risk conditions, and those with occupational exposure risks.

The approach failed. As someone who had to explain these complex eligibility requirements to confused patients, I can attest to the chaos it created. This limited approach created tremendous confusion among health care providers and patients alike. Pharmacies and clinics struggled to verify eligibility, people misunderstood their risk category and, ultimately, many high-risk individuals who genuinely needed boosters never received them.

Comments closed

Novavax

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

Published May 17, 2025

Published by: The New York Times
Published on: May 17, 2025
By Christina Jewett, Apoorva Mandavilli

The Food and Drug Administration on Friday approved the Novavax Covid-19 vaccine, but only for older adults and for others over age 12 who have at least one medical condition that puts them at high risk from Covid.

Scientific advisers to the Centers for Disease Control and Prevention, who typically make decisions on who should get approved shots and when, have been debating whether to recommend Covid shots only to the most vulnerable Americans. The F.D.A.’s decision appeared to render at least part of their discussion moot.

The new restriction will sharply limit access to the Novavax vaccine for people under 65 who are in good health. It may leave Americans who do not have underlying conditions at risk if a more virulent version of the coronavirus were to emerge. It could also limit options for people who want the vaccine for a wide array of reasons, including to protect a vulnerable loved one.

Comments closed

long COVID

Long COVID May Cause Long-Term Changes in the Heart and Lungs and May Lead to Cardiac and Pulmonary Diseases

Published May 6, 2025

Published by: Mount Sinai Health System
Published on: May 6, 2025

Mount Sinai study suggests COVID-19 infection should be considered a risk factor for future cardiopulmonary conditions

New York, NY (May 6, 2025) — Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection—even when standard medical tests return normal results—potentially placing them at elevated risk for future cardiac and pulmonary conditions. These findings come from a new study conducted by researchers at the Icahn School of Medicine at Mount Sinai and published April 30, in the Journal of Nuclear Medicine.

The study, the largest of its kind using advanced PET/MRI imaging, discovered significant abnormalities in cardiovascular and pulmonary tissues, as well as altered levels of circulating immune-regulating proteins, in long COVID patients. These abnormalities could serve as early warning signs of diseases such as heart failure, valvular heart disease, and pulmonary hypertension.

Comments closed

vaccines

VA study: Pfizer COVID booster 68% effective against hospitalization

Published May 2, 2025

Published by: CIDRAP
Published on: May 2, 2025
By Stephanie Soucheray

A study published earlier this week in Nature Communications using claims data from the US Veterans Affairs (VA) Healthcare System finds protection from the 2024-25 Pfizer COVID-19 vaccine was 68%, 57%, and 56% against COVID-19–associated hospitalizations, emergency department and urgent care (ED/UC) visits, and outpatient visits, respectively.

However, the authors caution that uptake of the vaccine was extremely low—only 3.7% through November 2024—and the study did not assess waning effectiveness.

The study estimated early BNT162b2 KP.2 (2024-25 formulation) vaccine effectiveness (VE) against COVID-19 outcomes compared to not receiving the vaccine.

Comments closed

Ottawa: Contact councillors — save our wastewater monitoring!

Image of a chart with a plot of virus concentrations over time. Navy blue background with white text reading: Save our science — protect Ottawa's wastewater monitoring! Text in red: No data.

take action

Ottawa: Contact councillors — save our wastewater monitoring!

Published May 2, 2025

📣 Let municipal councillors know you want funding for wastewater monitoring to continue

✉️ Send letters to municipal councillors in Ottawa to voice your support for wastewater monitoring. Use our online tool to send emails.

Why take action? The funding for Ottawa’s wastewater monitoring program is currently set to expire in September 2025. Wastewater monitoring is an essential public health tool that provides insights into the spread of SARS-CoV-2 and other viruses in Ottawa. We need an early warning system to inform everyone about the prevalence of SARS-CoV-2 subvariants, influenza, avian flu, RSV, mpox, and other viruses.

Comments closed

Yukon

2 doses of COVID-19 vaccine recommended for Yukoners at higher risk of severe illness

Published April 25, 2025

Published by: Yukon News
Published on: April 25, 2025
By Talar Stockton

In an April 24 press release, YG said it is acting on the advice of the Yukon’s chief medical officer of health, and the National Advisory Committee on Immunization.

Those who are eligible for the twice-per-year vaccination encompass multiple categories: people aged 6 months to 64 years who are moderately to severely immunocompromised due to an underlying condition or treatment; residents in long-term care homes and other congregate living settings for seniors; and adults 65 years or older.

Comments closed

long COVID

Possible treatments for long COVID at the centre of new Western study

Published April 24, 2025

Published by: CTV News
Published on: April 24, 2025
By Bailey Shakyaver

More than 300 patients across four continents are at the centre of a Western long COVID study, which hopes to find an effective treatment for those who struggle with long COVID.

The study will look to trial two anti-inflammatory medicines as potential treatments, and hopes to bring into view people who struggle with the disease outside of North America.

“Despite the global prevalence of long COVID, patients report different symptoms and their presentation can be influenced by where they happen to live,” said Dr. Douglas Fraser, professor at Western’s Schulich School of Medicine & Dentistry. “A study with global reach, tailored to examine each patient’s most severe symptoms, has the potential to bring hope to people well beyond Canada and the U.S.”

Comments closed

Tag: COVID-19

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

COVID-19 Exhibits Greater Disease Burden Than Influenza

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Mount Sinai study suggests COVID-19 infection should be considered a risk factor for future cardiopulmonary conditions

Still COVIDing Canada Posts

Still COVIDing Canada Posts

📣 Let municipal councillors know you want funding for wastewater monitoring to continue

Still COVIDing Canada Posts

Still COVIDing Canada Posts